[Medication errors in pediatrics]

Andrés Felipe Valencia Quintero1, Pedro Amariles2, Natalia Rojas Henao1

  • 1Hospital Pablo Tobón Uribe, Medellín, Colombia.

Insights

Medication errors are common in hospitalized children, with prescription errors being the most frequent. Understanding these errors helps in developing targeted interventions to improve pediatric patient safety.

Area of Science:

  • Pediatric patient safety
  • Medication error analysis
  • Healthcare quality improvement

Background:

  • Medication errors (ME) are preventable adverse events in medication use.
  • Pediatric patients are particularly vulnerable, with ME prevalence three times higher than in adults.
  • ME contribute to significant healthcare costs and can be fatal.

Purpose of the Study:

  • To determine the prevalence of medication errors in hospitalized pediatric patients.
  • To classify medication errors based on the stage of medication use.
  • To inform targeted interventions for reducing pediatric ME.

Main Methods:

  • Systematic literature review of studies published in the last 10 years.
  • Searched PubMed/Medline using "Medication Errors" and "Pediatrics".
  • Independent review of 22 eligible studies using STROBE checklist criteria.

Main Results:

  • Error rates ranged from 1% to 58% across studies.
  • Prescription errors, primarily incorrect dosage, were most common (41%).
  • Errors occurred across all stages: prescription, administration, preparation, and reconciliation.

Conclusions:

  • Medication errors are prevalent in pediatric populations.
  • Prescription and administration stages are key areas for ME.
  • Data on ME prevalence guides focused interventions to enhance pediatric safety.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
55
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
68
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
49
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
70
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
48
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.6K